![Frontiers | The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China Frontiers | The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China](https://www.frontiersin.org/files/Articles/981338/fnut-09-981338-HTML/image_m/fnut-09-981338-g001.jpg)
Frontiers | The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China
![Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial - The Lancet Oncology Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/a3f777d1-5306-4825-b4eb-3940fe263d72/gr1_lrg.jpg)
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial - The Lancet Oncology
![Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCASH2014/3/1/Slide05.jpg)
Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice
![The investigation and management of follicular lymphoma - McNamara - 2020 - British Journal of Haematology - Wiley Online Library The investigation and management of follicular lymphoma - McNamara - 2020 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2683ef90-b770-4cd4-a7a3-635d0ec9d2d4/bjh.16872.fp.png)
The investigation and management of follicular lymphoma - McNamara - 2020 - British Journal of Haematology - Wiley Online Library
![Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis - Biology of Blood and Marrow Transplantation Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/4d982194-d95a-4575-af5a-20f54abbbfa0/ybbmt54956-fig-0001_lrg.jpg)
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis - Biology of Blood and Marrow Transplantation
![Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study | Journal of Clinical Oncology Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2015.61.33.issue-23/jco.2014.59.7534/20161107/images/medium/zlj02315-5358-t02.jpeg)
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study | Journal of Clinical Oncology
![Upfront identification of high‐risk follicular lymphoma - Casulo - 2021 - Hematological Oncology - Wiley Online Library Upfront identification of high‐risk follicular lymphoma - Casulo - 2021 - Hematological Oncology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/03385750-9ce7-4628-a8c4-7ad684fb1c26/hon.v39.s1.cover.jpg?trick=1681528577935)
Upfront identification of high‐risk follicular lymphoma - Casulo - 2021 - Hematological Oncology - Wiley Online Library
![Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study - Link - 2019 - British Journal of Haematology - Wiley Online Library Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study - Link - 2019 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ef288771-4544-489a-94bf-d0740335a065/bjh.2019.184.issue-4.cover.jpg)
Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study - Link - 2019 - British Journal of Haematology - Wiley Online Library
![Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study - Link - 2019 - British Journal of Haematology - Wiley Online Library Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study - Link - 2019 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/beeab632-8c9a-4409-bfa0-c85ff405d788/bjh.15149.fp.png)
Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study - Link - 2019 - British Journal of Haematology - Wiley Online Library
![Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies | SpringerLink Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40487-021-00161-5/MediaObjects/40487_2021_161_Fig1_HTML.png)
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies | SpringerLink
![Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study - The Lancet Haematology Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study - The Lancet Haematology](https://www.thelancet.com/cms/asset/5fb0117c-a040-4730-9ba3-5129317f1415/gr1.jpg)
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study - The Lancet Haematology
![Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCASH2014/3/1/Slide01.jpg)
Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice
![A) Progression-free survival (PFS) of patients with stage I follicular... | Download Scientific Diagram A) Progression-free survival (PFS) of patients with stage I follicular... | Download Scientific Diagram](https://www.researchgate.net/publication/230723995/figure/fig1/AS:406903982182403@1474024877408/A-Progression-free-survival-PFS-of-patients-with-stage-I-follicular-lymphoma-in-the.png)
A) Progression-free survival (PFS) of patients with stage I follicular... | Download Scientific Diagram
![Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial | Nature Medicine Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01622-0/MediaObjects/41591_2021_1622_Fig1_HTML.png)